Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Applied Toxicology"
DOI: 10.1002/jat.3941
Abstract: ChAd3‐EBO‐Z is an investigational adenovirus‐based vaccine for the prevention of Ebola virus disease. Two nonclinical studies were performed to evaluate the biodistribution, local tolerance and potential local and systemic toxic effects of this vaccine. In…
read more here.
Keywords:
safety assessment;
biodistribution;
assessment repeated;
chad3 ebo ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Applied Toxicology"
DOI: 10.1002/jat.4404
Abstract: Herpes simplex virus type 2 (HSV‐2) is the most common cause of genital disease worldwide. The development of an effective HSV‐2 vaccine would significantly impact global health based on the psychological distress caused by genital…
read more here.
Keywords:
simplex virus;
nonclinical safety;
virus type;
two vaccine ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Human gene therapy"
DOI: 10.1089/hum.2022.090
Abstract: The nonclinical safety assessments for gene therapies are evolving, leveraging over 20 years of experimental and clinical experience. Despite the growing experience with these therapeutics, there are no approved harmonized global regulatory documents for developing…
read more here.
Keywords:
safety;
gene therapies;
nonclinical safety;
gene therapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-24-0087
Abstract: Abstract Nonclinical safety and pharmacokinetic data for monomethyl auristatin E (MMAE) and 14 vedotin antibody–drug conjugates (ADC) were evaluated to determine patterns of toxicity, consistency of pharmacokinetic results, and species differences between rats and monkeys.…
read more here.
Keywords:
toxicity;
antibody drug;
safety pharmacokinetic;
vedotin antibody ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Toxicologic Pathology"
DOI: 10.1177/0192623318792537
Abstract: Short interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs) are the most clinically advanced oligonucleotide-based platforms. A number of N-acetylgalactosamine (GalNAc)-conjugated siRNAs (GalNAc-siRNAs), also referred to as RNA interference (RNAi) therapeutics, are currently in various stages…
read more here.
Keywords:
rnai therapeutics;
galnac conjugated;
safety;
galnac sirnas ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Toxicologic Pathology"
DOI: 10.1177/01926233211003498
Abstract: Nonclinical evaluation of human safety risks for new chemical entities (NCEs) is primarily conducted in conventional healthy animals (CHAs); however, in certain instances, animal models of diseases (AMDs) can play a critical role in the…
read more here.
Keywords:
safety assessment;
safety;
pros cons;
nonclinical safety ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Toxicologic pathology"
DOI: 10.1177/01926233231164557
Abstract: Gliosis, defined as a nonneoplastic reaction (hypertrophy and/or proliferation) of astrocytes and/or microglial cells, is a frequent finding in the central nervous system (CNS [brain and/or spinal cord]) in nonclinical safety studies. Gliosis in rodents…
read more here.
Keywords:
brain spinal;
nonclinical safety;
safety studies;
pathology ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Toxicologic Pathology"
DOI: 10.1177/01926233241255125
Abstract: Digitalization of pathology workflows has undergone a rapid evolution and has been widely established in the diagnostic field but remains a challenge in the nonclinical safety context due to lack of regulatory guidance and validation…
read more here.
Keywords:
pathology minimal;
toxicologic pathology;
pathology;
nonclinical safety ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "International Journal of Toxicology"
DOI: 10.1177/10915818221095489
Abstract: COVID-19 is a potentially fatal infection caused by the SARS-CoV-2 virus. The SARS-CoV-2 3CL protease (Mpro) is a viral enzyme essential for replication and is the target for nirmatrelvir. Paxlovid (nirmatrelvir co-administered with the pharmacokinetic…
read more here.
Keywords:
paxlovid;
safety;
pharmacology;
development ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Life"
DOI: 10.3390/life14060759
Abstract: Atmospheric nonthermal plasma (ANTP) has rapidly evolved as an innovative tool in biomedicine with various applications, especially in treating skin diseases. In particular, the formation of reactive oxygen species (ROS) and nitrogen species (RNS), which…
read more here.
Keywords:
plasma;
role;
reactive species;
nonclinical safety ... See more keywords